companydata.dkcompanydata.dk

PHARMAKON A/S: Financial statements 2025

CVR: 10038839

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

PHARMAKON A/S (CVR 10038839) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 143,466,000 and a net result of DKK -3,206,000 compared with DKK 1,890,000 the year before. That is an increase of 1.5% compared with the year before. The profit margin was -2.2%. Equity in the 2025 report amounted to DKK 98,649,000. The solvency ratio was 82.2%. The company had 135 employees in the financial year.

Revenue
DKK 143,466,000
Gross Profit
DKK 95,204,000
Profit/Loss
DKK -3,206,000
Equity
DKK 98,649,000
Total Assets
DKK 120,024,000
Employees
135

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025143.5M95.2M-3.2M98.6M135
2024141.4M94.8M1.9M101.9M139
2023140.5M-5.1M100M131
2022128.9M-2.7M94.9M129
2021117.1M-8.3M92.1M120

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAKON A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Lars Pram Olsen joins the board of PHARMAKON A/SOct 27, 2025

As of October 27, 2025, Lars Pram Olsen has joined the board of directors of PHARMAKON A/S.

Tue Askaa leaves the board of PHARMAKON A/SOct 27, 2025

As of October 27, 2025, Tue Askaa has left the board of directors of PHARMAKON A/S.

Rikke Spangenberg leaves the board of PHARMAKON A/SJun 30, 2025

As of June 30, 2025, Rikke Spangenberg has left the board of directors of PHARMAKON A/S.

PHARMAKON A/S: The 2024 annual report is outJun 3, 2025

PHARMAKON A/S has published its annual report for 2024. Revenue came to DKK 141,350,000, and the net result was DKK 1,890,000.

PHARMAKON A/S wins public contractMar 21, 2025

PHARMAKON A/S has won the tender "16.07 Konferencer, seminarer og møder (2025) - Genudbud" issued by Staten og Kommunernes Indkøbsservice A/S worth 934,000,000 DKK.

Kirsten Holme Christensen joins the board of PHARMAKON A/SFeb 28, 2025

As of February 28, 2025, Kirsten Holme Christensen has joined the board of directors of PHARMAKON A/S.

Michael Bo Nielsen leaves the board of PHARMAKON A/SFeb 28, 2025

As of February 28, 2025, Michael Bo Nielsen has left the board of directors of PHARMAKON A/S.

Kirsten Holme Christensen leaves the board of PHARMAKON A/SFeb 27, 2025

As of February 27, 2025, Kirsten Holme Christensen has left the board of directors of PHARMAKON A/S.

About PHARMAKON A/S

PHARMAKON A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1986. The company is registered under the industry Drift af hoteller og lignende overnatningsfaciliteter. The company was previously named DANMARKS APOTEKERFORENINGS KURSUSEJENDOM A/S. The management consists of Lotte Fonnesbæk. The board consists of Lars Pram Olsen (chair), Anja Claudia Hoffmann, Ditte Poulsen and Jeanette Hovgaard Rasmussen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 170 employees (2026). In 2025, the company reported revenue of DKK 143,466,000 and a net result of DKK -3,206,000 compared with DKK 1,890,000 the year before. Equity in the 2025 report amounted to DKK 98,649,000.

Source: annual report 2025, Danish Business Authority